Non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues

  • Email
  • Help
Current effective versionRevision 1 - Adopted guideline
Reference numberEMEA/CHMP/BMWP/32775/2005 Rev. 1
Effective from01/09/2015
KeywordsRecombinant human insulin, insulin analogues, similar biological medicinal products, biosimilar, comparability, non-clinical studies, clinical studies, hyperinsulinaemic euglycaemic clamp, glucose clamp
DescriptionThis document lays down the non-clinical and clinical requirements for recombinant insulin-containing products, including human insulin and insulin analogues (both referred to as insulin), claiming to be similar to another one already authorised (the reference medicinal product).

Document history

Revision 1 

Current version

Adopted guideline

Overview of comments

Second draft guideline

First draft guideline

Concept paper

In operation: 01/09/2015–present

Published: 07/04/2015

Published: 30/04/2014

Published: 14/12/2012

Published: 27/07/2011

First versionAdopted guidelineIn operation: 01/06/2006–01/09/2015

Related content

How helpful is this page?

Average rating:

 Based on 28 ratings

Add your rating:

See all ratings
7 ratings
5 ratings
5 ratings
5 ratings
6 ratings

Tell us more